Literature DB >> 8002091

Continuous infusion of acyclovir is more effective than discontinuous infusion for treatment of genital herpes in an immunocompromised patient.

L Mock, L Dossou-Gbété, M Merle-Melet, A Gérard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8002091     DOI： 10.1007/BF01739921

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  10 in total

Review 1.  Resistance of herpesviruses to antiviral drugs.

Authors:  P A Chatis; C S Crumpacker
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

2.  A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.

Authors:  S Safrin; C Crumpacker; P Chatis; R Davis; R Hafner; J Rush; H A Kessler; B Landry; J Mills
Journal:  N Engl J Med       Date:  1991-08-22       Impact factor: 91.245

3.  Continuous infusion of high-dose acyclovir for serious herpesvirus infections.

Authors:  C V Fletcher; J A Englund; B Bean; B Chinnock; D M Brundage; H H Balfour
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

4.  Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome.

Authors:  C J Birch; G Tachedjian; R R Doherty; K Hayes; I D Gust
Journal:  J Infect Dis       Date:  1990-09       Impact factor: 5.226

5.  Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance.

Authors:  G Darby; H J Field; S A Salisbury
Journal:  Nature       Date:  1981-01-01       Impact factor: 49.962

6.  Selection and preliminary characterization of acyclovir-resistant mutants of varicella zoster virus.

Authors:  K K Biron; J A Fyfe; J E Noblin; G B Elion
Journal:  Am J Med       Date:  1982-07-20       Impact factor: 4.965

7.  Treatment of herpes virus infections in immunocompromised patients with acyclovir by continuous intravenous infusion.

Authors:  S A Spector; M Hintz; C Wyborny; J D Connor; R E Keeney; S Liao
Journal:  Am J Med       Date:  1982-07-20       Impact factor: 4.965

8.  Treatment of resistant herpes simplex virus with continuous-infusion acyclovir.

Authors:  J P Engel; J A Englund; C V Fletcher; E L Hill
Journal:  JAMA       Date:  1990 Mar 23-30       Impact factor: 56.272

9.  Acyclovir-resistant mutants of herpes simplex virus type 1 express altered DNA polymerase or reduced acyclovir phosphorylating activities.

Authors:  P A Furman; D M Coen; M H St Clair; P A Schaffer
Journal:  J Virol       Date:  1981-12       Impact factor: 5.103

10.  Treatment of cytomegalovirus retinitis with trisodium phosphonoformate hexahydrate (Foscarnet).

Authors:  S L Walmsley; E Chew; S E Read; H Vellend; I Salit; A Rachlis; M M Fanning
Journal:  J Infect Dis       Date:  1988-03       Impact factor: 5.226
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.